Sentien Biotechnologies

Developer of stem cell based device product for acute organ failure

placeLexington, Massachusetts, United States calendar_todayFounded 2008 groups7 employees language sentienbiotech.com

Registered entities

Investor mix

8 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Mission BioCapital.

Investor typeCountShare
Venture capital450%
Angel & family office113%
Accelerator & incubator113%
Other / undisclosed225%
Coming soon